These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 26888056)

  • 1. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
    Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant.
    Justinova Z; Munzar P; Panlilio LV; Yasar S; Redhi GH; Tanda G; Goldberg SR
    Neuropsychopharmacology; 2008 Nov; 33(12):2870-7. PubMed ID: 18305459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
    Schindler CW; Scherma M; Redhi GH; Vadivel SK; Makriyannis A; Goldberg SR; Justinova Z
    Psychopharmacology (Berl); 2016 May; 233(10):1867-77. PubMed ID: 26803499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB
    He XH; Jordan CJ; Vemuri K; Bi GH; Zhan J; Gardner EL; Makriyannis A; Wang YL; Xi ZX
    Acta Pharmacol Sin; 2019 Mar; 40(3):365-373. PubMed ID: 29967454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys.
    Justinova Z; Le Foll B; Redhi GH; Markou A; Goldberg SR
    Psychopharmacology (Berl); 2016 May; 233(10):1791-800. PubMed ID: 26149611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
    Ward SJ; Rosenberg M; Dykstra LA; Walker EA
    Drug Alcohol Depend; 2009 Dec; 105(3):248-55. PubMed ID: 19679410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.
    Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD
    Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).
    Diergaarde L; de Vries W; Raasø H; Schoffelmeer AN; De Vries TJ
    Neuropharmacology; 2008 Oct; 55(5):712-6. PubMed ID: 18588903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
    Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
    Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.
    Sink KS; Segovia KN; Nunes EJ; Collins LE; Vemuri VK; Thakur G; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2009 Oct; 206(2):223-32. PubMed ID: 19588124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area.
    Simonnet A; Cador M; Caille S
    Addict Biol; 2013 Nov; 18(6):930-6. PubMed ID: 22784230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
    de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
    Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
    Justinová Z; Ferré S; Redhi GH; Mascia P; Stroik J; Quarta D; Yasar S; Müller CE; Franco R; Goldberg SR
    Addict Biol; 2011 Jul; 16(3):405-15. PubMed ID: 21054689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice.
    Luján MÁ; Alegre-Zurano L; Martín-Sánchez A; Cantacorps L; Valverde O
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110462. PubMed ID: 34688811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats.
    Jing L; Qiu Y; Zhang Y; Li JX
    Drug Alcohol Depend; 2014 Oct; 143():251-6. PubMed ID: 25169627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
    Le Foll B; Goldberg SR
    J Pharmacol Exp Ther; 2005 Mar; 312(3):875-83. PubMed ID: 15525797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.